The UK Biobank Pharma Proteomics Project, the largest study of circulating proteins, is set to revolutionize healthcare by enabling earlier detection of diseases like cancer, dementia, and autoimmune conditions through blood tests. Backed by a consortium of pharma giants like Pfizer and AstraZeneca, the project will analyze protein levels from 600,000 blood samples, providing insights into how genes, lifestyle, and environment influence disease progression. Early findings reveal proteins linked to diseases years before diagnosis and the potential to repurpose existing drugs for new treatments.
World’s largest proteins study ‘invaluable’ for understanding disease – experts (Independent)
0